Ganglioglioma

Ganglioglioma is a rare type of brain tumor. It's usually a slow-growing, non-cancerous (benign) tumor. These tumors often occur in the optic nerve or the white matter of the brain or spinal cord. Doctors monitor these tumors carefully.

Condition

What people with Ganglioglioma report

Every report comes from a Lived member, sent anonymously.

Have you had Craniotomy for Ganglioglioma?

NameHow it went

About Ganglioglioma

What It Is

A ganglioglioma is a rare tumor of the brain or, less often, the spinal cord. It is made of two kinds of abnormal cells growing together: cells that resemble nerve cells (ganglion cells) and glial cells, the supporting cells of the nervous system. Most gangliogliomas are low-grade, meaning they grow slowly and tend to stay in one place rather than spreading through the brain. The tumor is found mainly in children and young adults, and most people are diagnosed before age 20. Its most common first sign is seizures. Gangliogliomas most often form in the temporal lobe, the part of the brain near the ears, which is especially prone to triggering seizures. For many people the seizures come first, sometimes for years, before a scan shows the tumor. Gangliogliomas are one of the most common tumors found in people having surgery for seizures that medicines do not control. Depending on where the tumor sits, other symptoms can include headaches, nausea, weakness on one side of the body, vision changes or problems with balance. A small number of gangliogliomas have more aggressive, high-grade features and behave more like a cancer, which changes how they are treated.

Causes & Risk Factors

Gangliogliomas develop when genetic changes inside the tumor cells switch on a growth-signaling pathway that normally stays tightly controlled. The most common changes are in a gene called BRAF. A single version, called V600E, is found in roughly 10% to 60% of these tumors (estimates vary between studies and testing methods), and other BRAF changes also occur. In most people these changes arise in the tumor itself; they are not inherited and are not caused by anything a person or parent did. No environmental cause has been identified. Most gangliogliomas occur in people with no special risk. A small share occur in people with neurofibromatosis type 1 (NF1), an inherited condition that raises the risk of several nervous system tumors.

How It's Diagnosed

Evaluation usually starts because of seizures or other neurological symptoms. A clinician takes a history and does a neurological exam, which checks strength, reflexes, coordination, eye movements and alertness. An electroencephalogram (EEG), which records the brain's electrical activity, helps show where seizures start. Magnetic resonance imaging (MRI) is the key imaging test. A ganglioglioma often appears as a well-defined area with a fluid-filled cyst and a solid part that lights up with contrast dye, frequently in the temporal lobe and often with little swelling around it. These features point toward the diagnosis but cannot confirm it, because several other slow-growing brain tumors look similar. The diagnosis is confirmed when tissue removed during surgery or a biopsy is examined under a microscope. The tissue is usually also tested for BRAF and related genetic changes. Those results help confirm the tumor type, can flag the uncommon tumors that are likely to behave more aggressively, and show whether targeted drugs could be an option later.

Treatment Options

Surgery is the main treatment. The goal is to remove the whole tumor when that can be done without harming important brain function, because complete removal gives the best chance that the tumor will not return and that seizures will stop. When the tumor causes seizures, the operation is often planned with an epilepsy team so the surgeon can also remove nearby brain tissue that is generating seizures. Tumors close to areas that control movement or speech, or deep in the brain, brainstem or spinal cord, may only be partly removable. When some tumor remains, the care team may simply watch it with scans, since many low-grade remnants grow very slowly. If the tumor grows, returns or has high-grade features, further options include another operation, radiation therapy and drug treatment. Targeted drugs have become an important choice for tumors with BRAF changes. Dabrafenib (Tafinlar) combined with trametinib (Mekinist), drugs that block two steps in the overactive growth pathway, is approved in the US for children 1 year and older with a low-grade glioma carrying V600E, the most common BRAF change, who need drug treatment. Tovorafenib (Ojemda), another BRAF-pathway blocker, is approved for children 6 months and older whose low-grade glioma with a BRAF change has come back or not responded to earlier treatment. These are pills or liquids taken at home, but they need ongoing monitoring for side effects, and how well they work specifically for ganglioglioma is still being studied. Clinical trials are another option for tumors that keep returning. Anti-seizure medicines help reduce seizures before surgery and are usually continued for a time afterward.

What to Expect

For most people the long-term outlook is very good. Published series report that 83% to 94% of people are alive 15 years after diagnosis, and many low-grade tumors do not return after complete removal. Outcomes are less favorable for the uncommon tumors with high-grade features or certain genetic combinations, and for tumors in places that cannot be fully removed. Seizure control is often the biggest practical change. Surgery can end seizures, but they return in some people, most often when tumor is left behind. Stopping anti-seizure medicine is a gradual decision made with the care team; in one national study, about 59% of children and 36% of adults had stopped it within five years of surgery. Until seizures are well controlled, they can affect driving, school, work and some activities, and those limits are reviewed as things improve. After treatment, people have regular follow-up visits and scans to watch for regrowth, often for years. Children may also benefit from checks on learning, memory and development, especially if they had seizures for a long time before surgery.

When to Seek Help

Arrange a prompt medical evaluation for repeated spells of staring, unusual sensations or unexplained behavior that could be seizures, or for headaches that are worse on waking and come with nausea or vomiting. If you already have a ganglioglioma, contact your care team promptly if seizures return or become more frequent, or if you notice new weakness, double vision, unsteady walking or changes in thinking or behavior, since these can signal regrowth or another problem that needs attention. Call 911 if someone has a seizure for the first time, if a seizure lasts longer than 5 minutes, or if seizures happen one after another without the person waking up in between.

Questions to Ask Your Doctor

  1. 1.How confident are we that this is a ganglioglioma, and did the tissue testing show a BRAF change or any features that suggest a more aggressive tumor?
  2. 2.Can the whole tumor be removed safely, and what are the risks to movement, speech or memory given its location?
  3. 3.What are the chances my seizures will stop after surgery, and when might we consider reducing or stopping anti-seizure medicine?
  4. 4.If some tumor is left or it comes back, would targeted therapy, radiation or a clinical trial make sense?
  5. 5.How often will I need follow-up scans, and what activities, such as driving, should I limit in the meantime?

Last reviewed • Oct 2026

Educational content, not medical advice.